Skip to main content
Clinical Trials/NCT01917955
NCT01917955CompletedNot Applicable

Cardiac MRI in Ischemic Stroke Study

Charite University, Berlin, Germany2 sites in 1 country103 target enrollmentStarted: January 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
103
Locations
2
Primary Endpoint
Sensitivity and specificity of contrast medium-enhanced cardiac magnetic resonance imaging to detect echocardiography-proven cardiac sources of embolism in patients with acute ischemic stroke.

Study Overview

Brief Summary

The purpose of this prospective single-center trial is to compare the safety and diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal echocardiography in patients with acute ischemic stroke.

Detailed Description

Primary safety objective: Contrast medium-enhanced cardiac magnetic resonance imaging is safe in patients with acute ischemic stroke. Primary outcome: The diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging is comparable to transesophageal echocardiography in patients with acute ischemic stroke.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with acute ischemic stroke detected by brain magnetic resonance imaging.

Exclusion Criteria

  • Known atrial fibrillation or cardiac source of embolism
  • Severe aphasia
  • Acute infection or chronic inflammation
  • Severe arteriosclerosis or stenosis of brain-supplying arteries
  • Contraindications for magnetic resonance imaging or transesophageal echocardiography.

Outcomes

Primary Outcomes

Sensitivity and specificity of contrast medium-enhanced cardiac magnetic resonance imaging to detect echocardiography-proven cardiac sources of embolism in patients with acute ischemic stroke.

Time Frame: < 1 week after ischemic stroke

Secondary Outcomes

  • Rate of unrecognised myocardial infarction detected by late gadolinium-enhanced cardiac MRI in patients with acute ischemic stroke.(< 1 week after ischemic stroke)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Karl Georg Haeusler

MD

Charite University, Berlin, Germany

Study Sites (2)

Loading locations...

Similar Trials